Safety, Pharmacokinetics,and Antiviral Activity of RV299 Against Respiratory Syncytical Virus (RSV)

Clinical trial NCT06067191 · COMPLETED

Trial details

NCT number: NCT06067191
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Respiratory Syncytial Virus (RSV)

Start date: 2022-08-08
Primary completion: 2022-12-02
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.